ArticleProceedings of the National Academy of Sciences of the United States of America2023

Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.